Jenny Shu

Jenny Shu serves as the Senior Director of Biology Immunology at LifeMine Therapeutics since April 2024. Prior to this role, Jenny Shu was the Senior Director and Head of Biology at Synlogic, Inc., leading discovery biology efforts focused on inflammatory bowel disease. Jenny Shu contributed significantly as the Principal Scientist and immunology team lead at Cygnal Therapeutics, developing the scientific strategy and immunology discovery platform. Earlier experiences include serving as a Senior Scientist at Jounce Therapeutics and roles at Harvard University and NKI-AVL as a Postdoctoral Fellow. Jenny Shu holds a PhD in Microbiology, Immunology, and Molecular Genetics from UCLA and a Master of Liberal Arts in Finance from Harvard University Extension School, complemented by a BS in Microbiology from Georgia Institute of Technology.